MyAverix Finance MyAverix Finance

US

BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)

BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) is listed on US. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for BCTXL

P/E ratio
18.00

BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) — FAQ

What is BCTXL's P/E ratio?

The price-to-earnings (P/E) ratio for BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) is 18.00 (data as of 2026-03-23).

Does BriaCell Therapeutics Corp. Warrant expiring 2031 pay a dividend?

Dividend yield is not available in the current snapshot for BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL). Check the MyAverix Finance app for the latest dividend data.

What exchange is BCTXL listed on?

BCTXL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play